Sidley Austin , White & Case and Wachtell, Lipton, Rosen & Katz are advising International Game Technology PLC on the transaction, and Paul, Weiss, Rifkind, Wharton...
You must be a Standard 1 Year member to access this content.
Sidley Austin is advising Angel City FC on the transaction; Milbank is advising Bob Iger and Willow Bay; Paul, Weiss, Rifkind, Wharton & Garrison , Venable...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented Hennessy Capital and the former directors of Hennessy Capital Acquisition Corp. IV on the deal. Hennessy Capital and the former directors of Hennessy...
You must be a Standard 1 Year member to access this content.
Sidley Austin represented Pretium Partners, LLC in the transaction, and Faegre Drinker Biddle & Reath represented BH Management Services, LLC. Pretium Partners, LLC (“Pretium”) announced that it...
You must be a Standard 1 Year member to access this content.
Sidley secured a victory on behalf of Tupperware Brands Corporation. On August 9, 2023, Tupperware Brands Corporation obtained a victory in the U.S. Court of Appeals for...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Bausch Health Companies Inc. in connection with the separation of its eye health business into a new publicly traded company, Bausch + Lomb...
You must be a Standard 1 Year member to access this content.
Sidley represented Linear Financial Technologies on the deal. Small business loan (SMB) and account origination platform, Linear Financial Technologies, announced its sale to Amount, a banking technology...
You must be a Standard 1 Year member to access this content.
Goodwin Procter, Fried Frank and Appleby advised LumiraDx Limited on the deal, while Sidley Austin LLP acted for CA Healthcare Acquisition Corp. LumiraDx Limited announced its...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP advised Tempest Therapeutics, Inc. on the deal. Tempest Therapeutics, Inc., a privately-held, clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted...
You must be a Standard 1 Year member to access this content.
Sidley Austin LLP advised Tempest Therapeutics, Inc. on the deal. Tempest Therapeutics, Inc., a privately-held, clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted...
You must be a Standard 1 Year member to access this content.
